Delivery Order SPE2DB22D2005-SPE2DB24FJPR9

Award Date 7/8/24
Potential Completion Date 7/9/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,009.36 delivery order has a completion date of June 7, 2024 and is a firm fixed price contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for up to $999,999,999.00 to provide a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,031.96 firm-fixed-price contract has a completion date of May 7, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,612.52 firm fixed price contract has a completion date of June 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract valued at $3,789.86. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $1,161.12 Firm Fixed Price Delivery Order for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 4, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides $3,364.68 for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a prescription medication, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $3,364.68 and an ultimate completion date of June 7, 2024. This is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical product. The $1,741.68 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,773.64 and a period of performance ending on June 25, 2024. This is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen holds a larger, single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product TRULICITY 3 MG/0.5 ML PEN 0.5ML to the Defense Logistics Agency (DLA). The award, valued at $1,741.68, is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a potential total value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The fixed-price delivery order, valued at $2,919.12, was issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJPR9
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of 4565083282 TRULICITY 3 MG/0.5 ML PEN 0.5ML. The contract, valued at $2,031.96, is a firm fixed price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of July 9, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This particular award is not designated as a set-aside contract.

Generated 10/7/24, 10:56 AM